Stock ScreenerStock IdeasBiotech BreakthroughsBest Biotech Stocks To Buy NowTop biotech stocks that analysts expect to be profitable within the next 3 years
Stock ScreenerStock IdeasBiotech Breakthroughs
Industry: Biotechnology
Forecast Earnings Growth: Positive
| Ticker | Company | Market Cap | Price | Price Target | Upside/Downside | Top Analysts Upside/Downside | Consensus | Top Analysts Consensus | Analysts | Top Analysts | Fore. Revenue Growth | Fore. Earnings Growth | Forecast ROE | Forecast ROA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ONC | BEONE MEDICINES LTD | $34.45B | $311.02 | $390.88 | 25.68% | Strong Buy | 8 | 128.29% | 1,035.17% | 3,594.17% | 1,944.49% | |||
| CORT | CORCEPT THERAPEUTICS INC | $4.02B | $38.20 | $101.25 | 165.05% | Strong Buy | 4 | 44.80% | 101.92% | 181.22% | 139.04% | |||
| NVO | NOVO NORDISK A S | $232.79B | $52.39 | $57.40 | 9.56% | Buy | 5 | 96.31% | 97.21% | 537.07% | 178.12% | |||
| ALNY | ALNYLAM PHARMACEUTICALS INC | $52.87B | $400.17 | $491.28 | 22.77% | Strong Buy | 25 | 37.32% | 307.74% | 1,486.28% | 71.65% | |||
| KNSA | KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | $3.18B | $42.01 | $51.33 | 22.21% | Strong Buy | 6 | 25.55% | 80.85% | 41.88% | 31.47% | |||
| ZVRA | ZEVRA THERAPEUTICS INC | $469.52M | $8.34 | $22.00 | 163.79% | Strong Buy | 3 | 53.54% | 77.67% | 139.83% | 68.93% | |||
| VCEL | VERICEL CORP | $1.80B | $35.61 | $51.50 | 44.62% | Strong Buy | 2 | 21.63% | 84.43% | 29.97% | 21.28% | |||
| ARGX | ARGENX SE | $51.27B | $839.99 | $1.03k | 22.26% | Strong Buy | 15 | 1,549.26% | 23.80% | 56.41% | 47.92% | |||
| KRYS | KRYSTAL BIOTECH INC | $7.16B | $246.91 | $217.80 | -11.79% | Buy | 5 | 36.80% | 30.09% | 75.26% | 69.06% | |||
| GMAB | GENMAB A | $20.43B | $31.82 | $43.75 | 37.49% | Strong Buy | 4 | 16.73% | 133.44% | 31.20% | 25.56% | |||
| TECH | BIO-TECHNE CORP | $9.29B | $59.65 | $70.33 | 17.91% | Strong Buy | 9 | 6.53% | 73.19% | 22.68% | 17.65% | |||
| LGND | LIGAND PHARMACEUTICALS INC | $3.74B | $190.11 | $243.50 | 28.08% | Strong Buy | 6 | 14.25% | 69.75% | 25.11% | 16.16% | |||
| ADMA | ADMA BIOLOGICS INC | $4.26B | $17.88 | N/A | N/A | N/A | N/A | 27.01% | 23.78% | 118.79% | 90.07% | |||
| ABEO | ABEONA THERAPEUTICS INC | $287.76M | $5.31 | $20.00 | 276.65% | Buy | 2 | 817.16% | 17.10% | 98.46% | 72.95% | |||
| MNKD | MANNKIND CORP | $1.72B | $5.60 | $10.08 | 80.05% | Strong Buy | 6 | 21.75% | 60.18% | -453.45% | 40.84% | |||
| VCYT | VERACYTE INC | $3.35B | $42.39 | $45.50 | 7.34% | Buy | 6 | 13.01% | 70.57% | 15.42% | 14.18% | |||
| RPRX | ROYALTY PHARMA PLC | $22.43B | $38.86 | $45.75 | 17.73% | Strong Buy | 4 | 18.58% | 57.53% | 44.49% | 22.12% | |||
| CRMD | CORMEDIX INC | $958.07M | $12.16 | $18.40 | 51.32% | Buy | 5 | 29.70% | 5.75% | 70.46% | 35.11% | |||
| NAGE | NIAGEN BIOSCIENCE INC | $498.79M | $6.25 | $13.00 | 108.00% | Strong Buy | 2 | 23.38% | 31.11% | 72.56% | 52.26% | |||
| EXEL | EXELIXIS INC | $11.68B | $43.58 | $44.94 | 3.12% | Buy | 16 | 13.01% | 24.88% | 72.21% | 55.26% | |||
| VRTX | VERTEX PHARMACEUTICALS INC | $114.71B | $452.13 | $490.06 | 8.39% | Buy | 18 | 10.80% | 20.63% | 41.78% | 29.11% | |||
| HALO | HALOZYME THERAPEUTICS INC | $8.27B | $70.31 | $77.13 | 9.69% | Buy | 8 | 18.07% | 29.40% | 218.75% | 49.63% | |||
| PLX | PROTALIX BIOTHERAPEUTICS INC | $139.93M | $1.74 | $12.00 | 589.66% | Buy | 1 | 15.12% | 152.57% | 29.17% | 18.76% | |||
| BMRN | BIOMARIN PHARMACEUTICAL INC | $11.42B | $59.45 | $86.91 | 46.19% | Strong Buy | 11 | 8.93% | 35.89% | 23.71% | 18.85% | |||
| APLS | APELLIS PHARMACEUTICALS INC | $3.27B | $25.86 | $36.77 | 42.18% | Buy | 13 | 7.81% | 36.38% | 59.45% | 22.52% | |||
| AUPH | AURINIA PHARMACEUTICALS INC | $2.02B | $15.35 | $17.25 | 12.38% | Buy | 4 | 19.22% | 30.63% | 46.23% | 32.06% | |||
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | $2.15B | $37.38 | $45.00 | 20.39% | Strong Buy | 6 | 16.87% | 36.05% | 77.91% | 53.85% | |||
| CPRX | CATALYST PHARMACEUTICALS INC | $2.85B | $23.15 | $33.00 | 42.55% | Strong Buy | 1 | 9.04% | 18.84% | 57.36% | 50.19% | |||
| MDXG | MIMEDX GROUP INC | $959.70M | $6.48 | $11.00 | 69.75% | Strong Buy | 2 | 14.25% | 33.63% | N/A | N/A | |||
| INVA | INNOVIVA INC | $1.49B | $19.87 | $32.25 | 62.30% | Buy | 4 | 10.65% | 12.32% | 25.83% | 18.25% | |||
| REGN | REGENERON PHARMACEUTICALS INC | $81.59B | $776.31 | $787.63 | 1.46% | Buy | 16 | 8.17% | 10.23% | 21.11% | 16.27% | |||
| UTHR | UNITED THERAPEUTICS CORP | $21.39B | $496.72 | $495.08 | -0.33% | Buy | 12 | 11.18% | 8.41% | 27.79% | 24.91% | |||
| ACAD | ACADIA PHARMACEUTICALS INC | $4.45B | $26.29 | $31.08 | 18.23% | Buy | 12 | 12.14% | 5.80% | 45.58% | 31.42% | |||
| INCY | INCYTE CORP | $19.91B | $101.42 | $98.63 | -2.76% | Buy | 16 | 10.30% | 19.27% | 19.49% | 14.32% |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.